Cogent Biosciences, Inc. (COGT) vs Sotera Health Company (SHC)

A side-by-side comparison of Cogent Biosciences, Inc. and Sotera Health Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COGT vs SHC

growth of $100 · dividends reinvested · last 6y
COGT +206.9% (+20.5%/yr)SHC -26.1% (-4.9%/yr)COGT compounded faster over this window
0100200300400Start $100202120222023202420252026$307$74
COGT SHC

COGT vs SHC: by the numbers

  • •SHC is the larger company ($5.20B vs $5.19B market cap).
  • •SHC is profitable (13.44% net margin) while COGT runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCOGTSHC
P/E ratioN/A31.88
Forward P/EN/A18.53
P/S ratioN/A4.28
P/B ratio11.107.82
EV / EBITDAN/A12.43
FCF yieldN/A2.17%

Profitability

MetricCOGTSHC
Gross margin0.00%54.72%
Operating margin0.00%36.24%
Net margin0.00%13.44%
ROE-70.85%24.56%
ROIC-50.09%8.80%

Growth (annualized)

MetricCOGTSHC
Revenue CAGR (5Y)N/A6.66%
FCF CAGR (5Y)N/A17.34%
Total return CAGR (5Y)28.51%-6.39%

Frequently asked

Is COGT or SHC more profitable?
SHC runs the higher net margin — COGT at 0.00% versus SHC at 13.44%.
How have COGT and SHC total returns compared?
Over the past 5 years, COGT delivered 28.51% and SHC delivered -6.39% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.